A strong and positive correlation exists between chronic disease and affective disorders, but the biological mechanisms underlying this relationship are not known. Here we show that rats with mammary cancer exhibit depression-and anxiety-like behaviors in the absence of overt sickness behaviors. The production of proinflammatory cytokines, known to induce depressive-like behaviors, was elevated in the periphery and in the hippocampus of rats with tumors compared with controls. In tumor-bearing rats, circulating corticosterone, which inhibits cytokine signaling, was suppressed following a stressor, and gene expression of hippocampal glucocorticoid receptors was elevated. The results establish that tumors alone are sufficient to trigger changes in emotional behaviors. Dampened glucocorticoid responses to stressors may exacerbate the deleterious effects of tumor-induced cytokines on affective states.
A strong and positive correlation exists between chronic disease and affective disorders, but the biological mechanisms underlying this relationship are not known. Here we show that rats with mammary cancer exhibit depression-and anxiety-like behaviors in the absence of overt sickness behaviors. The production of proinflammatory cytokines, known to induce depressive-like behaviors, was elevated in the periphery and in the hippocampus of rats with tumors compared with controls. In tumor-bearing rats, circulating corticosterone, which inhibits cytokine signaling, was suppressed following a stressor, and gene expression of hippocampal glucocorticoid receptors was elevated. The results establish that tumors alone are sufficient to trigger changes in emotional behaviors. Dampened glucocorticoid responses to stressors may exacerbate the deleterious effects of tumor-induced cytokines on affective states.
cancer ͉ depression ͉ HPA ͉ hippocampus P hysical and psychological health share a bidirectional relationship (1-4). Individuals suffering from major peripheral illnesses (e.g., cancer, cardiovascular disease, AIDS, etc.) are at greater risk for depression and anxiety disorders relative to the healthy population (5-7). For example, mood disorders are reported in up to 60% of breast cancer patients (8) (9) (10) . Co-morbid depression is associated with decreased cancer survivorship (11) and increased treatment noncompliance (12) ; therefore, understanding the mechanisms underlying cancer-associated depression is of profound clinical significance. Despite the strong association between cancer and mood disorders, the respective contributions of: (i) subjective disease awareness, (ii) toxic side-effects of chemotherapy, and (iii) direct biological effects of tumors in the pathogenesis of cancerassociated affective disorders have remained largely unexamined and undifferentiated (13) (14) (15) .
Tumor cells secrete cytokines and chemokines locally (16, 17) . Proinflammatory cytokines (primarily IL-1␤, IL-6, and TNF␣) induce depressive-like behavior (e.g., anhedonia, anorexia, lethargy) (18) via humoral and neural signaling from the periphery to the brain (19) . The overwhelming majority of data relating peripheral proinflammatory cytokine production to alterations in behavior and affective states are generated using acute bacterial infection models (18, 19) , not chronic disease models. Information on the effects of tumors or tumor-induced cytokines on behavior, on the other hand, is limited to the study of cancer-induced anorexia or cachexia (20) . Thus, the hypothesis that tumor-derived cytokines contribute to cancer-induced depression has never been examined.
Cytokine signaling can be regulated by neuroendocrine activity, principally through the production of glucocorticoids (21) . Corticosterone suppresses the synthesis and actions of proinflammatory cytokines and can thereby inhibit the effects of proinflammatory cytokines on depressive-like behaviors (22) (23) (24) (25) . Because glucocorticoid production changes during progression of chronic disease (26) , the consequences of tumor-formation on glucocorticoid production and central negative feedback regulation may be germane to the mechanisms underlying cancer-induced changes in affective states.
Here we tested the hypothesis that tumors alone induce depression and trigger peripheral and central proinflammatory cytokine production. We also examined whether changes in the capacity of the hypothalamic-pituitary-adrenal (HPA) axis to provide negative regulation of cytokine signaling occur in parallel with the emergence of cancer-induced behavioral depression.
LPS-induced hippocampal IL-1␤, 229.3 Ϯ 68.1; IL-6, 71.1 Ϯ 13.0; TNF␣, 55.3 Ϯ 30.9 pg/mg). Consistent with lower levels of proinflammatory cytokine production, ''sickness behaviors'' were absent in tumor-bearing rats. Mass-specific food intake, rectal temperature, percent change in body mass, and the duration of social investigation were all comparable between NMU-injected tumorbearing rats and controls (P Ͼ 0.05 in all cases; Fig. 4 A-D, respectively), but several classical sickness behaviors (anorexia, somatic wasting, and decreases in social investigation) were evident in LPS-treated rats, and absent in tumor-bearing rats (Fig. 4 A, B , and D; P Ͻ 0.05 for all comparisons; values of peak LPS-induced mass-specific food intake, 0.041 Ϯ 0.01 g/g; rectal temperature, 33.9 Ϯ 0.6°C; change in body mass, Ϫ1.4 Ϯ 0.7%; investigation time, 35.5 Ϯ 5.2 s).
Tumors Suppress Glucocorticoid Responses and Increase Sensitivity of the HPA Axis Negative Feedback Loop. Basal corticosterone (CORT) concentrations did not differ among tumor-bearing (n ϭ 8) and control rats (n ϭ 6) before injection treatments, after injections but before tumor detection, or after tumor detection (P Ͼ 0.05; Fig.  5A ). Plasma CORT concentrations increased in all rats immediately after a 30-min swim stressor, but rats with tumors exhibited lower stress-induced CORT concentrations relative to controls (P Ͻ 0.05; Fig. 5B ). One hour poststressor, CORT did not differ between groups (P Ͼ 0.05; Fig. 5B ).
Dexamethasone treatment suppressed CORT equally in both groups of rats (P Ͼ 0.05; Fig. 5C ), but rats with tumors exhibited significant increases in gene expression of both mineralocorticoid receptors (MR) and glucocorticoid receptors (GR) in the hippocampus (P Ͻ 0.05 both comparisons; Fig. 5D ). MR and GR expression in the hypothalamus and pituitary did not differ between groups (P Ͼ 0.05; Fig. 5D ).
Discussion
Mammary tumors alone induced depressive-and obsessivecompulsive anxiety-like behaviors, stimulated cytokine production in a brain region that participates in the generation of these behaviors, and modestly altered regulation of the HPA axis. Tumor induction of emotional behaviors has not previously been demonstrated. A depressive-like state was inferred from behavioral despair in the Porsolt forced swim test and anhedonia in the sucrose consumption test. Decreases in sucrose consumption were evident when rats with tumors were given a mildly rewarding, low concentration of sucrose (0.1%), whereas a preference for highly rewarding stimuli (1% sucrose solution) was unaffected in tumor-bearing rats. Together these data suggest that tumors induce anhedonia by altering the threshold of reward. The observed increases in behavioral despair and anhedonia, in the absence of measurable overt sickness behaviors, indicate a selective effect of tumors on emotional behaviors.
NMU-treated rats did not exhibit depressive-like behavior before tumor formation, nor did rats that eventually developed tumors display depressive-like behavior before NMU-treatment, suggesting that neither carcinogen treatment nor a predisposition to depression was responsible for the depressive-like behaviors that emerged following tumor formation. Moreover, the general ab- sence of anxiety-like behaviors in tumor-bearing rats suggests that tumors alone are not sufficient to induce a global state of anxiety. The behavioral difference observed in the marble-burying test may reflect the unique facet of anxiety-like behavior (obsessivecompulsive anxiety-like behavior) assayed by this test, as compared to elevated plus maze and open field tests of fearful versus exploratory anxiety-like behaviors. A potential explanation for this observation is that depressive-like behaviors and obsessivecompulsive anxiety-like behaviors share a common underlying neurotransmitter pathway (serotonin) (28) different from that which underlies classical anxiety-like behaviors (GABA) (29) .
Following tumor detection, the majority of elevated peripheral and central cytokines were proinflammatory (IL-1␤, IL-6, TNF␣), well-established mediators of acute changes in behavior observed following bacterial infection and brain trauma (18, 30, 31) . Elevations in proinflammatory cytokines in the absence of overt sickness behaviors may illustrate important differences between chronic and acute disease states. Compared to models of acute infection, rats with tumors (i.e., chronic disease) do not exhibit sickness behavior, and we infer that longer intervals of relatively modest increases in peripheral and central cytokine production must exist. Prolonged exposure to modest elevations in cytokines has been shown to induce anxiety-like behaviors in rodents (32, 33) and learning deficits and emotional behavior in humans (34) (35) (36) . Low magnitude increases in cytokine production over time frames typical of tumor formation (weeks to months) may be sufficient to mediate changes in affective states.
Although the majority of the cytokines that increased in tumorbearing rats are proinflammatory, significant increases in hippocampal IL-10, which counteracts increases in proinflammatory cytokine production (37), were also detected. IL-10 may function as a negative regulator of proinflammatory cytokine activity in the brain during chronic disease states. Whether and how cytokines originating from tumors gain access to or trigger local cytokine production in the brain to increase depressive-like behavior is not currently known, but both neural and humoral routes may participate (15, 38) . The present data do not permit specification of the cellular sources of increased brain cytokine production following tumor formation.
Coincident with increases in proinflammatory cytokine production following tumor formation were modest alterations in the HPA axis. Changes in basal CORT in rats with tumors were not detected before or after tumor detection, indicating that preexisting differences in CORT do not predispose rats to tumor development. However, rats with tumors exhibited significantly dampened CORT responses immediately following a stressor. Glucocorticoids inhibit the synthesis and action of proinflammatory cytokines and their receptors (22, 23, 25, 39) . Decreased CORT production exacerbates behavioral responses to proinflammatory cytokines (40, 41) , and CORT replacement treatments that mimic poststressor CORT levels antagonize cytokine effects on behavior more effectively than treatments that only restore baseline CORT concentrations (42, 43) . The dampening of glucocorticoid responses in the presence of elevated cytokine production may reflect a breakdown in immuneendocrine negative feedback regulation of cytokine signaling following tumor development. Over time scales relevant to chronic disease, dampened CORT responses to daily stressors in tumorbearing rats may amplify the effects of modest increases in circulating cytokines, and this process may contribute to elevations in central cytokine production and the observed depressive-like behaviors (44) . Increases in hippocampal MR and GR in tumorbearing rats are consistent with the observed modest diminution of stress-induced CORT responses (45) and may provide a central mechanism by which tumors impair regulation of the HPA axis. In summary, changes in proinflammatory cytokine production and HPA axis regulation following tumor production indicate that cancers are capable of affecting emotional state via direct (elevations in brain proinflammatory cytokines) and indirect (dampened glucocorticoid responses) mechanisms, although the relative contributions of these 2 mechanisms are not yet understood. Together, increases in hippocampal cytokine production and GR gene expression suggest that the hippocampus may be a neural substrate at which endocrine and immune signaling converge to induce depressive-like behavior in chronic disease states.
Whereas caution must be taken in extrapolating these data to cancer patients, the animal model described here may afford basic insights into the mechanisms by which peripheral, chronic disease alters brain function. As examples, neuropsychiatric (e.g., depressed or anxious mood, anhedonia) and neurovegetative/somatic (e.g., anorexia, fatigue, pain) dimensions of depression can be dissociated (46) , and cortisol responses to acute stressors are dampened in cancer patients (47); these observations parallel those of the present report. Moreover, an additional insight afforded by the present approach is that that the behavioral and physiological sequelae to tumors occurred in the absence of disease awareness or chemotherapeutic intervention, suggesting that a proportion of the variance in human mood disorders concurrent with cancer may be attributable to the effects of tumors alone on affective states.
Materials and Methods
Animals. Female, nulliparous Wistar rats from Harlan were used in these experiments. Siblings were pseudorandomly distributed among all groups and grouphoused (2-3/cage) in polypropylene cages (25.9 cm ϫ 47.6 cm ϫ 20.9 cm high) with a constant temperature and humidity of 22 Ϯ 1°C and 50 Ϯ 5%, respectively, and ad libitum access to food (Harlan 8640 rodent diet) and filtered tap water. Rats were housed under a light-dark cycle consisting of 16-h light/day (lights illuminated at 20:00 CST).
Tumor Induction. Between 30 -42 d of age, rats received an injection (i.p., 50 mg/kg) (48, 49) of a standard chemical carcinogen (NMU in saline, pH 4.0; Sigma) or a saline injection. All cagemates received the same treatment. NMU induces Ͼ90% malignant mammary tumors (ductal carcinomas) in rats that are comparable in origin and mutation to the most common type of breast tumor in women (50 -52) . Body mass was measured weekly, and weekly tumor palpation commenced 3-5 weeks postinjection [onset of palpable (Ͼ3 mm) tumors range: 5-10 weeks post-NMU injection]. Tumors that develop after this window are less likely to be malignant (53); NMU-injected rats that did not develop palpable tumors within this window were excluded from the study. At week 7, all rats were separated into individual cages in anticipation of behavioral testing (weeks 8 -10). Separate cohorts of rats were used for each experiment. Because of the large variation in tumor size (1-50 g), data analysis was restricted to rats with tumors within 1.5 SD from mean tumor mass (range: 4.7-15.2 g).
Tumor Effects on Depressive-and Anxiety-Like Behaviors. Twenty-four rats were used in this experiment (n ϭ 12 saline, n ϭ 12 NMU). Testing of depressive-and anxiety-like behaviors commenced 1-3 weeks after tumor palpation. The Porsolt forced swim and sucrose anhedonia tests were used to assess depressive-like behavior, and the elevated plus, marble burying, and open field tests were used to assess anxiety-like behaviors (as described below). All behavioral testing occurred on separate days between 08:00 -10:00 CST in the following order: open field, marble burying, sucrose anhedonia, elevated plus, Porsolt forced swim.
The possibility that innate depressive-like behavior may predispose rats to NMU-induced tumor development was also tested in this experiment. In a separate cohort of rats (n ϭ 15), depressive-like behaviors were measured via the Porsolt forced swim test at 39 -45 d of age followed by NMU injection 2 d later. Weekly tumor palpation was recorded for 10 weeks postinjection to determine whether rats that innately display depressive-like behavior were more likely to develop tumors. In another cohort of rats, the possibility the chemical, NMU, alters affective states independently from tumor development was also tested. Tumor-independent effects of NMU were assessed by measuring depressive-like behavior (via Porsolt) in rats after NMU (or saline) injection but before tumor emergence [1.5 weeks postinjection (54 d of age); n ϭ 12/group].
Tumor Effects on Local, Circulating, and Limbic Cytokine Production. Thirty rats were used in this experiment (n ϭ 15 saline, n ϭ 15 NMU). One to 3 weeks after tumor palpation, rats were rapidly decapitated (between 10:00 -12:00 CST), and tissues were collected. Trunk blood was stored on ice until centrifugation (4°C, 30 min at 3,000 rpm) and frozen at Ϫ80°C for cytokine analysis. Tumors (or mammary tissue from saline controls) were excised and weighed, and a 0.5 g sample was flash-frozen on dry ice. The hypothalamus and hippocampus were removed, halved, and flash-frozen on dry ice.
For comparison of cytokine levels and sickness behaviors to a standard cytokine-induced depression model, 51 additional rats were injected with lipopolysaccharide (LPS) (Escherichia coli, 127:8B; 250 g/kg, i.p.; Sigma) or pyrogen-free saline, and tissues were collected as described above 2, 6, and 72 h postinjection (n ϭ 6/group/time), or sickness behaviors were measured as described below. Finally, a third cohort of rats was used to measure potential ''overt'' sickness behaviors (anorexia, weight loss, fever, and social inhibition) following tumor induction. Tumors were induced as described above, and within 2 weeks of tumor detection, daily food intake was averaged over 4 consecutive days, change in body mass was averaged over 4 consecutive days, and rectal temperature averaged over 2 consecutive days, in single-housed tumor-bearing (n ϭ 7) and saline-treated controls (n ϭ 9). After 3 d of rest, social exploration was assessed using a standard sickness behavior protocol (54) . Briefly, a juvenile male rat (27-34 d of age) was placed inside the home cage of the experimental rat for 5 min within 1 h after lights-off, and behavior was videotaped. Videotapes were later scored by 2 investigators unaware to the treatments for the number and duration of time that the female experimental rat spent actively sniffing the juvenile using Etholog freeware (v. 2.2.5). Measurement of LPS-induced sickness behaviors occurred 3 days before (baseline) and 24, 48, and 72 h post-LPS injection for food intake and body mass, 2 days before and 2, 24, and 36 h postinjection for rectal temperature (LPS, n ϭ 6; saline, n ϭ 4), and 3 h post-LPS injection for social investigation (LPS, n ϭ 5; saline, n ϭ 4).
Tumor Effects on the HPA Axis. Thirty-two rats were used in this experiment (n ϭ 6 saline, n ϭ 27 NMU). Blood was sampled retro-orbitally from all rats for basal corticosterone assessment before injection treatments, and 2 d later, rats received an NMU or saline injection (as described above). Basal blood was then sampled every 2 weeks after injection to correlate changes in corticosterone with tumor emergence. Basal corticosterone concentrations were compared retrospectively with the first blood sample at or within 1 week after tumor emergence designated as the week of ''tumor detection''. Within 2 weeks of tumor palpation (weeks 8 -10 postinjection), 3 aspects of the HPA axis were systematically assessed in tumor-bearing and saline-treated rats: (i) corticosterone response to a stressor, (ii) central HPA sensitivity (via DEX challenge), and (iii) central negative feedback regulation (via GC receptor expression) in rats with tumors and saline controls. All assessments were separated by 2-3 d to minimize potential carryover effects. Times of the HPA challenges were chosen such that blood/tissues were sampled at approximately the same time of day (2 h before lights-off).
Cytokine Analysis. IL-1␣, IL-1␤, IL-2, IL-4, IL-6, IL-10, GM-CSF, IFN␥, and TNF␣ were measured in tumor/mammary and brain tissue (50 g protein/mL) and in serum samples (12 L) using a multiplex fluorescent bead array (Bio-Plex Rat 9-Plex Cytokine Panel; Bio-Rad) validated for this species (55) according the manufacturer's protocol at the Flow Cytometry Facility at the University of Chicago. This assay uses antibodies to each cytokine that are covalently bonded to color-coded polystyrene beads. Beads bind individual cytokines and are detected and quantified simultaneously via unique wavelengths.
Blood Sampling. Rats were anesthetized with isoflurane vapors, and approximately 250 L of blood were sampled from the retro-orbital sinus (2 h before lights-off). Blood was kept on ice until centrifugation (4°C, at 3,000 rpm) and then frozen at Ϫ80°C.
Dexamethasone Suppression Test.
Rats received a 30 g/kg dexamethasone (D1159; Sigma) injection 3 h before blood sampling (2 h before lights-off) for endogenous corticosterone measurement.
Corticosterone Measurement. Corticosterone was measured using ELISAs (Correlate-EIA kit; Assay Designs) according to the manufacturer's instructions (plasma samples were diluted 1:60). The corticosterone ELISA had a sensitivity of Ͻ27.0 pg/mL, an intra-assay CV of 7.7%, and an inter-assay CV of 9.7%. All samples, standards, and replicates were assayed in duplicate.
qPCR. Total RNA was extracted (RNeasy Mini Kit; Qiagen), and RNA quality was verified by A260/A280 ratios Ͼ1.8 on a spectrophotometer. Following reverse transcription, Primer Express software (v. 3.0; Applied Biosystems) was used to design primers and a probe based on GenBank sequencing information for Rattus MR and GR (accession nos: MR NM013131, GR NM012576). Primers and probes were synthesized as follows, with probes labeled with 6-FAM and MGB (nonfluorescent quencher) at the 5Ј and 3Ј ends, respectively: MR forward 5Ј-CGCACAGCAATATGAAAACCATA-3Ј, MR reverse 5Ј-ACACCTCGTCTGCATGCT-GTAT-3Ј, MR probe 5Ј-TTCGAAGGCGATAAAC-3Ј; GR forward 5Ј-CCCCCAACTA-AATCGCTAATACA-3Ј, GR reverse 5Ј-TCGGTGCGGGTGAGATGT-3Ј, GR probe 5Ј-CAAGAATGGCTAGACACC-3Ј. A TaqMan 18S Ribosomal RNA primer and probe set (labeled with VIC; Applied Biosystems) was used as the control gene for relative quantification. Amplification was performed on an ABI 7900HT Sequencing Detection System at the Functional Genomics Center at University of Chicago by using Taqman Universal PCR Master Mix. The universal 2-step RT-PCR cycling conditions used were: 50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Relative gene expression of individual samples run in duplicate was calculated by comparison to relative standard curve consisting of serial dilutions of pooled rat hippocampal cDNA (1:1, 1:10, 1:100, 1:1000, 1:10,000) followed by normalization to 18S rRNA gene expression.
Porsolt Forced Swim Test. This standard measure of depressive-like behavior operationalizes behavioral despair as the time spent floating (versus active escape) in an inescapable water tank (27°C, 40 cm deep ϫ 30 cm dia), which can be reversed by antidepressant treatment (56) . On the first day of testing, rats were exposed to the water tank for 15-min (pretest). On day 2, a 5-min test was performed. The amount of time spent swimming and climbing (escape behaviors) and floating (behavioral despair) were estimated using a real-time sampling technique (57) . Video for one of the saline rats was damaged and therefore not included in the analysis.
Sucrose Anhedonia. Anhedonia, or the inability to experience sensations of pleasure, was quantified via consumption (or decreases therein) of a palatable sucrose solution (58) . Tests were performed over 3 days: (day 1) 24 h access to 2 water bottles, (day 2) 3 h access to water bottle alongside bottle containing 0.1% or 1% sucrose, (day 3) 24 h access to a water bottle alongside a 0.1% or 1% sucrose bottle (positions switched after 12 h). Consumption of sucrose solution relative to water was used as a measurement of sucrose preference.
Marble-Burying Test.
To test obsessive-compulsivity (an anxiety-related behavior), rats were placed in a clean cage containing 20 marbles placed atop 4 cm corncob bedding material. The number of marbles buried in the bedding after 20 min was recorded (28). 3 m 2 ) . Decreases in center entries and time spent in the center region are interpreted as anxiety-like behaviors (59) . Rats were placed in the Plexiglas arena for 15 min, and behavior was videotaped. Scoring by a blind experimenter using Ethovision determined total distance moved and duration, frequency, and latency to enter the center of the open field.
Swim Stressor. These rats were subjected to a 30-min swim stressor followed by blood sampling, immediately and 1 h poststressor, for corticosterone measurement. The swim stress consisted of placing the rats in a bucket (40 cm deep ϫ 30 cm dia) of 27°C water for 30 min. Statistical Analyses. StatView 5.0 software (v. 5.0.1; SAS) was used to perform all statistics. Evaluation of differences between groups over time was performed using repeated measures ANOVA; factorial ANOVA was used to compare multiple treatment groups at a single time point. Student's t test was used to perform multiple pairwise comparisons where warranted by a significant omnibus F-statistic. Differences were considered significant if P Ͻ 0.05.
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